MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women

Inclusion Criteria: Additional screening criteria check may apply for qualification: * Provide written informed consent to participate in this study * Spontaneous amenorrhea for ≥12 months; or spontaneous amenorrhea for at least 6 months and with follicle stimulating hormone (FSH) levels \>40 mIU/mL; or documented bilateral salpingo oophorectomy ≥6 weeks, with or without hysterectomy * 7 or more moderate to severe VMS per day, or 50 or more moderate to severe VMS per week * Have a consistent bedtime on at least 5 nights per week * Mean VMS frequency during the Placebo Run in period does not drop by more than 50% from the mean level reported for 2 weeks during the Screening period * VMS diary compliance \>50% * In the Investigator's opinion, subject is able to understand the nature of the study and any risk involved in participation, and is willing to cooperate and comply with the protocol restrictions and requirements Exclusion Criteria: Additional screening criteria check may apply for qualification: * History of any cancer within 5 years except for basal cell carcinoma * History of undiagnosed abnormal vaginal bleeding * History of Hepatitis B, Hepatitis C or HIV * History of psychiatric illness, excessive alcohol intake or use of recreational drugs who are unsuitable for study enrollment and compliance * Presence or history of severe adverse reaction or allergy to any drug * Peripheral vascular disease or disorders with associated vasculopathies * Clinically significa…